Source comparison
Cyclists BPC-157 Protocol: Dosing vs Recovery Timeline Comparison
250mcg daily Localized (2–3 inches from injury) 4–6 weeks Pain reduction 2–3 points on VAS; improved ROM in 3 weeks Appropriate for mild tendinopathies; dose may be subtherapeutic for chronic cases 500mcg daily 6–8 weeks Pain reduction 3–5 points on VAS; retur
This comparison does not assign a generated winner or score.
- 250mcg daily
- Localized (2–3 inches from injury)
- 4–6 weeks
- Pain reduction 2–3 points on VAS; improved ROM in 3 weeks
- Appropriate for mild tendinopathies; dose may be subtherapeutic for chronic cases
- 500mcg daily
- 6–8 weeks
- Pain reduction 3–5 points on VAS; return to modified training in 4–5 weeks
- Standard protocol for moderate-to-severe tendinopathies; supported by anecdotal evidence
- 250–500mcg daily
- Systemic (abdominal fat)
- Any duration
- Minimal to no localized benefit
- Mechanistically inefficient; peptide doesn't reach injury site at therapeutic concentration
- 750mcg+ daily
- Localized
- 4–8 weeks
- Marginal additional benefit vs 500mcg; increased risk of localized edema
- Dosing above 500mcg daily shows diminishing returns; no evidence of improved efficacy